It is believed to be mainly active in adults in contrast to IGF-2, which is also a major fetal growth factor
Who Should Avoid GLP-1 Medications Genetic and Cancer Concerns If you or your family has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2), GLP-1 medications come with an increased risk of thyroid C-cell tumors and should be avoided
Regardless of severity, treatment almost always starts with a high-fiber diet and other lifestyle modifications that include bowel movement behaviors
The meta-regression analysis suggested that the apparent protective association of GLP-1RAs may emerge relatively early in treatment, a finding consistent with randomized trials reporting improvements in walking capacity after short-term therapy
After 4 weeks at therapeutic doses, most users report 50-70% reduction in pain, significantly improved function, and ability to resume modified training or activities